Literature DB >> 25775640

Management of Onychomycosis in Canada in 2014.

Aditya K Gupta1, Maryse Paquet2.   

Abstract

BACKGROUND: Onychomycosis has several clinical presentations and is caused by various infectious organisms.
OBJECTIVE: To provide guidance for selection of appropriate treatment.
METHODS: The literature on onychomycosis management was reviewed to generate an evidence-based decision tree. RESULTS AND
CONCLUSION: Several options are available: terbinafine, itraconazole, fluconazole, ciclopirox 8% nail lacquer, efinaconazole 10% nail solution, and laser therapy. Further studies on lasers are needed before use can be recommended. Nondermatophyte molds or mixed infection can be managed with terbinafine or itraconazole with or without topicals. Itraconazole, fluconazole, and efinaconazole can be used for Candida infection. For dermatophytes, topicals can be considered for mild to moderate onychomycosis. For moderate to severe cases, any oral monotherapy can be used; however, we suggest terbinafine if there is a possibility of a drug interaction. These recommendations can be applied for all ages, immune function, or metabolic status, but proper monitoring and contraindications should be taken into consideration.
© 2014 Canadian Dermatology Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25775640     DOI: 10.2310/7750.2014.14090

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  5 in total

Review 1.  A Paradigm Shift in the Treatment and Management of Onychomycosis.

Authors:  Aditya K Gupta; Maanasa Venkataraman; Helen J Renaud; Richard Summerbell; Neil H Shear; Vincent Piguet
Journal:  Skin Appendage Disord       Date:  2021-05-11

Review 2.  Onychomycosis Caused by Fusarium Species.

Authors:  Eduardo Vinicius Grego Uemura; Marcelo Dos Santos Barbosa; Simone Simionatto; Ahmed Al-Harrasi; Abdullah M S Al-Hatmi; Luana Rossato
Journal:  J Fungi (Basel)       Date:  2022-03-31

3.  Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.

Authors:  Martha F Mushi; Gustave Buname; Oliver Bader; Uwe Groß; Stephen E Mshana
Journal:  BMC Infect Dis       Date:  2016-09-02       Impact factor: 3.090

4.  Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.

Authors:  Ken Iozumi; Masatoshi Abe; Yoshiko Ito; Takashi Uesugi; Takashi Onoduka; Ichiro Kato; Fumihiro Kato; Kazuo Kodama; Hidetoshi Takahashi; Osamu Takeda; Koki Tomizawa; Tomoko Nomiyama; Mizue Fujii; Jun Mayama; Fumio Muramoto; Hidemi Yasuda; Kiyomitsu Yamanaka; Tomotaka Sato; Tsunao Oh-I; Hiroko Kasai; Ryoji Tsuboi; Naoko Hattori; Ryuji Maruyama; Tokuya Omi; Harunari Shimoyama; Yoshihiro Sei; Ichiro Nakasu; Shuhei Nishimoto; Yasuki Hata; Takashi Mochizuki; Masao Fukuzawa; Mariko Seishima; Kazumitsu Sugiura; Ichiro Katayama; Osamu Yamamoto; Masahisa Shindo; Hiroe Kiryu; Masahiro Kusuhara; Motoi Takenaka; Shinichi Watanabe
Journal:  J Dermatol       Date:  2019-06-17       Impact factor: 4.005

5.  Self-controlled Study of Onychomycosis Treated with Long-pulsed Nd:YAG 1064-nm Laser Combined with Itraconazole.

Authors:  Yan Li; Jing Xu; Jun-Ying Zhao; Feng-Lin Zhuo
Journal:  Chin Med J (Engl)       Date:  2016-08-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.